$BRCTF News
Last published 2w ago
- 2w agoBRCTFBIOABioArctic's Nomination Committee appointedPR NewswireSTOCKHOLM, October 30, 2026 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced the composition of its Nomination Committee for the 2027 Annual General Meeting. The Nomination Committee has
- 2w agoBRCTFNew clinical data on lecanemab to be presented at CTAD conference 2026PR NewswireSTOCKHOLM, October 30, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new clinical and real-world evidence on lecanemab (Leqembi®) at the Clinical Trials on
- 2w agoBRCTFSales of Leqembi® totaled 32.2 billion yen in the third quarter 2026PR NewswireSTOCKHOLM, October 28, 2026 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi for the third quarter 2026, in conjunction with